Newly described salivary gland tumors
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články, přehledy
PubMed
28060365
DOI
10.1038/modpathol.2016.167
PII: S0893-3952(22)02342-0
Knihovny.cz E-zdroje
- MeSH
- adenokarcinom diagnóza genetika patologie MeSH
- adenom diagnóza genetika patologie MeSH
- fúzní onkogenní proteiny genetika MeSH
- lidé MeSH
- nádorové biomarkery genetika MeSH
- nádory slinných žláz diagnóza genetika patologie MeSH
- prognóza MeSH
- sekreční karcinom mamárního typu diagnóza genetika patologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
- Názvy látek
- fúzní onkogenní proteiny MeSH
- nádorové biomarkery MeSH
This review concentrates on three salivary gland tumors that have been accepted in the recent literature as new neoplastic entities: mammary analog secretory carcinoma (MASC), sclerosing polycystic adenoma (SPA) and cribriform adenocarcinoma of tongue and other minor salivary glands (CAMSGs). MASC is a distinctive low-grade malignant salivary cancer that harbors a characteristic chromosomal translocation, t(12;15) (p13;q25) resulting in an ETV6-NTRK3 fusion. SPA is a rare lesion often mistaken histologically for low-grade salivary carcinoma. Previously thought to be a reactive fibroinflammatory process, but recent evidence of clonality, recurrences in up 30%, and dysplastic foci suggest it may be truly neoplastic. CAMSG is a distinct tumor entity that differs from polymorphous low-grade adenocarcinoma (PLGA) by location (ie, most often arising on the tongue), by prominent nuclear clearing, alterations of the PRKD gene family and clinical behavior with frequent metastases at the time of presentation of the primary tumor. Early metastatic disease seen in most cases of CAMSG associated with indolent behavior makes it a unique neoplasm among all low-grade salivary gland tumors. Salivary glands may give rise to a wide spectrum of different tumors. They are often diagnostically challenging as morphological features often overlap between different entities. Although conventional morphology in combination with immunohistochemical findings still provide the most important clues for diagnosis, recent advances in molecular pathology offer new diagnostic tools in investigating the differential diagnosis, as well as providing potentially valuable prognostic indicators. In the last two decades, several new salivary gland tumor entities have been described, namely MASC, SPA and CAMSGs.
Department of Anatomical Pathology Foothills Medical Centre Calgary Alberta Canada
Department of Pathology Charles University Faculty of Medicine in Plzen Plzen Czech Republic
Zobrazit více v PubMed
Am J Surg Pathol. 2012 Jan;36(1):27-34 PubMed
Cancer Cytopathol. 2013 May;121(5):228-33 PubMed
Am J Surg Pathol. 2015 May;39(5):602-10 PubMed
Oral Surg Oral Med Oral Pathol. 1990 Oct;70(4):480-2 PubMed
Cancer Cytopathol. 2013 May;121(5):234-41 PubMed
Am J Surg Pathol. 2000 Jul;24(7):937-46 PubMed
Diagn Pathol. 2011 Mar 15;6:19 PubMed
Nat Genet. 2014 Nov;46(11):1166-9 PubMed
Eur Ann Otorhinolaryngol Head Neck Dis. 2010 Mar;127(1):20-2 PubMed
Arch Otolaryngol Head Neck Surg. 2004 Mar;130(3):357-60 PubMed
Kulak Burun Bogaz Ihtis Derg. 2012 Sep-Oct;22(5):288-92 PubMed
Acta Cytol. 1994 Mar-Apr;38(2):247-51 PubMed
Mod Pathol. 2014 Jan;27(1):30-7 PubMed
Case Rep Pathol. 2014;2014:982432 PubMed
Ann Oncol. 2016 May;27(5):920-6 PubMed
Am J Surg Pathol. 2011 Oct;35(10):1600-2 PubMed
Arch Otolaryngol. 1983 Dec;109(12):827-31 PubMed
Arch Pathol Lab Med. 1991 Feb;115(2):141-4 PubMed
Arch Otolaryngol Head Neck Surg. 2010 Apr;136(4):385-92 PubMed
Biochem Biophys Res Commun. 2012 Dec 7;429(1-2):87-92 PubMed
Head Neck Pathol. 2013 Jul;7 Suppl 1:S30-6 PubMed
Am J Surg Pathol. 1996 Feb;20(2):161-70 PubMed
Am J Surg Pathol. 2016 Jan;40(1):3-13 PubMed
Head Neck Pathol. 2014 Mar;8(1):42-9 PubMed
Head Neck Pathol. 2013 Jul;7 Suppl 1:S3-11 PubMed
Am J Pathol. 1998 Nov;153(5):1451-8 PubMed
Histopathology. 1998 Jun;32(6):521-9 PubMed
Nat Genet. 2003 Feb;33(2):208-13 PubMed
J Craniofac Surg. 2012 Sep;23(5):e451-2 PubMed
Genes Chromosomes Cancer. 2014 Oct;53(10):845-56 PubMed
Hum Pathol. 2015 Jan;46(1):94-103 PubMed
Virchows Arch. 2012 Nov;461(5):531-40 PubMed
Clin Exp Otorhinolaryngol. 2013 Jun;6(2):107-9 PubMed
Virchows Arch. 2002 Jan;440(1):29-35 PubMed
Hum Pathol. 2013 Sep;44(9):1937-40 PubMed
Mod Pathol. 2016 Sep;29(9):985-95 PubMed
Int J Clin Exp Pathol. 2014 Dec 01;7(12):9008-22 PubMed
Oncol Lett. 2011 Jan;2(1):135-138 PubMed
Cancer Cell. 2002 Nov;2(5):367-76 PubMed
J Oral Maxillofac Surg. 1992 Jun;50(6):595-600 PubMed
Am J Surg Pathol. 2016 Nov;40(11):1526-1537 PubMed
Histopathology. 2011 Jul;59(1):90-7 PubMed
Head Neck Pathol. 2015 Mar;9(1):85-95 PubMed
Head Neck Pathol. 2013 Mar;7(1):35-9 PubMed
Cytopathology. 2009 Apr;20(2):130-2 PubMed
Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Sep;120(3):e174-6 PubMed
Ophthalmology. 2013 Apr;120(4):873-873.e1 PubMed
Am J Surg Pathol. 2006 Aug;30(8):939-44 PubMed
Diagn Cytopathol. 2010 May;38(5):368-73 PubMed
Diagn Cytopathol. 2007 Jul;35(7):444-7 PubMed
Cancer Res. 1998 Nov 15;58(22):5046-8 PubMed
Am J Surg Pathol. 2016 Aug;40(8):1051-61 PubMed
Virchows Arch. 2014 Oct;465(4):371-84 PubMed
Cancer Cell. 2007 Dec;12(6):542-58 PubMed
Ear Nose Throat J. 2004 Jan;83(1):62-4 PubMed
Pol J Pathol. 2011 Sep;62(3):168-71 PubMed
Head Neck Pathol. 2016 Sep;10 (3):405-13 PubMed
Nat Genet. 1998 Feb;18(2):184-7 PubMed
Am J Surg Pathol. 2013 Jul;37(7):1053-7 PubMed
Histopathology. 2012 Sep;61(3):387-94 PubMed
Am J Surg Pathol. 2011 Aug;35(8):1168-76 PubMed
Head Neck Pathol. 2011 Jun;5(2):188-92 PubMed
Histopathology. 1999 Dec;35(6):495-501 PubMed
Pathol Res Pract. 2010 Aug 15;206(8):565-71 PubMed
Head Neck Pathol. 2012 Jun;6(2):247-9 PubMed
Virchows Arch. 2011 Jul;459(1):117-8 PubMed
Braz J Otorhinolaryngol. 2010 Mar-Apr;76(2):272 PubMed
Histopathology. 2016 Jun;68(7):1055-62 PubMed
Am J Surg Pathol. 2006 Feb;30(2):154-64 PubMed
Hum Pathol. 2013 Nov;44(11):2501-8 PubMed
Mod Pathol. 2015 Aug;28(8):1084-100 PubMed
Acta Otorrinolaringol Esp. 2013 Jan-Feb;64(1):78-80 PubMed
Pol J Pathol. 2016 Mar;67(1):84-90 PubMed
Acta Cytol. 2004 Jul-Aug;48(4):569-73 PubMed
Diagn Cytopathol. 2014 Dec;42(12):1085-90 PubMed
Cancer. 2014 Mar 15;120(6):799-807 PubMed
Adv Anat Pathol. 2013 Nov;20(6):367-77 PubMed
Diagn Cytopathol. 2015 Apr;43(4):287-93 PubMed
Hum Pathol. 2013 Oct;44(10):1982-8 PubMed
Head Neck Pathol. 2008 Mar;2(1):31-5 PubMed
J Oral Maxillofac Surg. 1989 Jan;47(1):86-8 PubMed
Pathologe. 1997 Sep;18(5):368-73 PubMed
Head Neck Pathol. 2013 Jul;7 Suppl 1:S97-106 PubMed
Diagn Cytopathol. 2014 Jan;42(1):49-53 PubMed
Pathol Res Pract. 2014 Jun;210(6):342-5 PubMed
Head Neck Pathol. 2013 Dec;7(4):316-9 PubMed
Cancer Res. 2011 Feb 1;71(3):1060-70 PubMed
Virchows Arch. 2015 Mar;466(3):245-54 PubMed
Br J Oral Maxillofac Surg. 2007 Jan;45(1):74-6 PubMed
B-ENT. 2006;2(4):189-92 PubMed
Histopathology. 2016 Apr;68(5):641-7 PubMed
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Oct;104(4):516-20 PubMed
Mod Pathol. 2012 Jul;25(7):919-29 PubMed
Pathol Res Pract. 2013 Mar;209(3):167-72 PubMed
Cytojournal. 2014 Aug 28;11:24 PubMed
Am J Surg Pathol. 2014 Jan;38(1):23-33 PubMed
Korean J Pathol. 2013 Feb;47(1):36-43 PubMed
Am J Surg Pathol. 2012 Mar;36(3):343-50 PubMed
Acta Cytol. 2013;57(2):207-12 PubMed
Ann Pathol. 2013 Dec;33(6):398-401 PubMed
Virchows Arch. 2014 May;464(5):621-5 PubMed
Am J Surg Pathol. 2010 May;34(5):599-608 PubMed
Polymorphous adenocarcinoma of the salivary glands: reappraisal and update